Literature DB >> 33308095

Progress in Traditional Chinese Medicine for the Treatment of Migraine.

Yanleng Huang1, Ni Ni1, Yanlong Hong2, Xiao Lin1, Yi Feng3, Lan Shen1.   

Abstract

Migraine is a recurrent disease with complex pathogenesis and is difficult to cure. At present, commercially available western migraine drugs are prone to generate side effects while treating the disease. Traditional Chinese medicine (TCM) avoids side effects via treatment with the principles of "treating both symptoms and root causes", "overall adjustment", and "treatment based on syndrome differentiation". Three strategies of drug treatment were developed based on the syndromes, i.e., removing stasis, calming liver Yang, and reinforcing deficiency. Prescriptions of removing stasis mostly contain Chuanxiong rhizome (Chuan Xiong) to remove blood stasis by promoting blood circulation and improve properties of hemorheology, and Da Chuan Xiong Formula (DCXF) is a traditional prescription widely used in clinical practice. Prescriptions of calming liver Yang usually take Ramulus Uncariae cum Uncis (Gou Teng) as the main herb, which can calm the liver Yang via improving vasomotor function, and Tian Ma Gou Teng Decoction (TMGTD) is the representative drug. For reinforcing deficiency, Chinese doctors frequently utilize Angelica Sinensis (Dang Gui) and Astragali Radix (Huang Qi) to nourish blood and Qi in order to improve the weak state of human body; Dang Gui Bu Xue Decoction (DGBXD) is the commonly used prescription. These strategies not only treat the symptoms of diseases but also their root causes, and with the features of multiple targets, in multiple ways. Therefore, TCM prescriptions have obvious advantages in the treatment of chronic diseases such as migraine. In this review, we provided an overview of the pathogenesis of migraine and the function of representative TCM preparations in therapy of migraine as well as the mechanism of action according to effective researches, in order to provide reference and clue for further researches.

Entities:  

Keywords:  Calming Liver Yang; Migraine; Reinforcing Deficiency; Removing Stasis; Traditional Chinese Medicine

Mesh:

Substances:

Year:  2020        PMID: 33308095     DOI: 10.1142/S0192415X2050086X

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  6 in total

1.  Network Pharmacology-Based Investigation on Therapeutic Mechanisms of the Angelica dahurica Radix and Ligusticum chuanxiong Rhizoma Herb Pair for Anti-Migraine Effect.

Authors:  Chu Duc Thanh; Chu Van Men; Hyung Min Kim; Jong Seong Kang
Journal:  Plants (Basel)       Date:  2022-08-24

2.  Effects of ligustrazine on the expression of neurotransmitters in the trigeminal ganglion of a rat migraine model.

Authors:  Hui Li; Fanghui Bai; Cong Cong; Baotian Chen; Wei Xie; Shasha Li; Qiang Liu; Chaojun Chen; Yanhua Wu
Journal:  Ann Transl Med       Date:  2021-08

3.  Exploring the Potential Mechanism of Chuanxiong Rhizoma Treatment for Migraine Based on Systems Pharmacology.

Authors:  Xianhua Wen; Yuncheng Gu; Beili Chen; Feipeng Gong; Wenting Wu; Hengli Tong; Qianfeng Gong; Songhong Yang; Lingyun Zhong; Xuping Liu
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-28       Impact factor: 2.629

4.  BushenHuoxue Recipe for the Treatment of Prethrombotic State of ACA-Positive Recurrent Miscarriage via the Regulation of the PI3K-AKT Signaling Pathway.

Authors:  Xuan Yang; Shulan Su; Qingling Ren; Lijing Liu; Jiashang Li; Wen Zhang; Ke Cai; Zhuo Xu; Xin Pan
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-14       Impact factor: 2.629

Review 5.  An Overview of Systematic Reviews of Chinese Herbal Medicine in the Treatment of Migraines.

Authors:  Guojing Fu; Xueming Fan; Xiao Liang; Jingjing Wei; Min Jia; Shaojiao Liu; Wei Shen; Yunling Zhang
Journal:  Front Pharmacol       Date:  2022-07-25       Impact factor: 5.988

6.  Xiongshao Zhitong Recipe Attenuates Nitroglycerin-Induced Migraine-Like Behaviors via the Inhibition of Inflammation Mediated by Nitric Oxide Synthase.

Authors:  Song Yang; Cong Chen; Xiaoyao Liu; Qianjun Kang; Quantao Ma; Pin Li; Yujie Hu; Jialin Li; Jian Gao; Ting Wang; Weiling Wang
Journal:  Front Pharmacol       Date:  2022-07-19       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.